CD274 and thyroid gland carcinoma: A recent systematic review and meta-analysis of the programmed death-ligand 1 (PD-L1) expression level in thyroid carcinoma pointed to the PD-L1 protein expression as a potential biomarker of disease-recurrence in patients with PTC [37].